| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $41.4M | -13.3% |
| SG&A Expense | $16.7M | -30.5% |
| Operating Income | -$58.0M | -669.2% |
| Income Tax | $0 | -100.0% |
| Net Income | -$58.0M | -576.9% |
| EPS (Basic) | -$6.83 | -2629.6% |
| EPS (Diluted) | -$6.83 | -2629.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $141.2M | +44.1% |
| Current Assets | $146.9M | +46.5% |
| Total Assets | $152.9M | +51.3% |
| Current Liabilities | $11.6M | +82.7% |
| Total Liabilities | $12.1M | +90.9% |
| Stockholders' Equity | $140.8M | +48.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.1M | +6.5% |
| Capital Expenditures | $156K | +1850.0% |
| Investing Cash Flow | -$156K | -100.2% |
| Financing Cash Flow | $171.7M | +1171.3% |
| Free Cash Flow | -$59.2M | +6.3% |